WebJan 1, 2006 · REACH was an international, prospective, observational registry that followed patients with or at high risk of atherothrombosis from 44 countries. Baseline data were collected, and patients were followed for up to 4 years. Principal Findings: WebJagasia M, Perales MA, Schroeder MA, et al. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial. Blood . 2024;135(20):1739-1749. Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft …
WebDec 21, 2016 · Brief Summary: The purpose of this study is to demonstrate that treatment with avelumab in combination with RT-cetuximab is superior to standard of care (SOC) … Web1 day ago · CNN's Nick Paton Walsh walks with migrants attempting to cross the Darien Gap, a perilous jungle crossing between Colombia and Panama as they head north to seek … how to sprint on xbox
Fulcrum
WebSep 20, 2024 · The GORTEC-REACH study also demonstrated no benefit for avelumab-based treatment in cisplatin-unfit patients, with a 2-year PFS rate of 44% versus 31% with standard of care (HR 0.84; one-sided p=0.14). “The numerical improvements in PFS and in 2-year locoregional control rate (HR 0.83) with avelumab-based treatment did not reach … Web6 hours ago · La Liga president Javier Tebas believes that FC Barcelona have already agreed to sign Lionel Messi this summer, according to transfer market expert Gerard Romero. … WebMar 8, 2024 · The REACH trial expects to enroll around 230 adults with FSHD. Participants will be randomly assigned to losmapimod, administered orally as a 15 mg tablet twice a day, or a placebo, for 48 weeks. The trial’s main goal is to assess changes from pre-treatment (baseline) in reachable workspace. reach for the gun lyrics